References of "DELANAYE, Pierre"
     in
Bookmark and Share    
Full Text
See detailThe concept of frailty in patients on dialysis
DELANAYE, Pierre ULiege

Scientific conference (2017, December 14)

Detailed reference viewed: 2 (2 ULiège)
Full Text
See detailEstimation du débit de filtration glomérulaire
DELANAYE, Pierre ULiege

Scientific conference (2017, December 07)

Detailed reference viewed: 9 (0 ULiège)
Full Text
See detailDébit de filtration glomérulaire : estimations et mesures
DELANAYE, Pierre ULiege

Scientific conference (2017, November 24)

Detailed reference viewed: 12 (0 ULiège)
Full Text
See detailAcute renal failure: definition and detection
DELANAYE, Pierre ULiege

Conference (2017, June 13)

Detailed reference viewed: 14 (1 ULiège)
Full Text
See detailGFR and drug dosage adaptation: are we still in the mist?
DELANAYE, Pierre ULiege

Conference (2017, June 13)

Detailed reference viewed: 15 (0 ULiège)
Full Text
See detailBone Markers and Vascular Calcification in CKD-MBD
DELANAYE, Pierre ULiege

Conference (2017, June 10)

Detailed reference viewed: 14 (0 ULiège)
Full Text
Peer Reviewed
See detailThe diagnostic value of rescaled renal biomarker serum creatinine and serum cystatin C and their relation with measured glomerular filtration rate.
Pottel, H; Dubourg, L; Schaeffner, E et al

in Clinica Chimica Acta (2017), 471

Detailed reference viewed: 27 (0 ULiège)
Full Text
Peer Reviewed
See detailCKD-EPI equation: a suitable glomerular filtration rate estimate for drug dosing in HIV-infected patients
Gagneux-Brunon, A; Bothelo-Nevers, E; DELANAYE, Pierre ULiege et al

in Médecine et Maladies Infectieuses (2017), 47(4), 266-270

Detailed reference viewed: 17 (0 ULiège)
Full Text
Peer Reviewed
See detailEpidemiology of chronic kidney disease: think (at least) twice!
DELANAYE, Pierre ULiege; Glassock, RJ; De Broe, ME

in Clinical Kidney Journal (2017), 10(3), 370-374

Detailed reference viewed: 22 (0 ULiège)
Full Text
See detailEvaluation de la fonction rénale
DELANAYE, Pierre ULiege

Conference (2017, March 14)

Detailed reference viewed: 23 (1 ULiège)
Full Text
See detailMeasuring and estimating GFR
DELANAYE, Pierre ULiege

Conference given outside the academic context (2017)

Detailed reference viewed: 16 (0 ULiège)
Full Text
Peer Reviewed
See detailAnalytical and clinical validation of the new Abbot Architect 25(OH)D assay: fit for purpose?
Cavalier, Etienne ULiege; LUKAS, Pierre ULiege; BEKAERT, Anne-Catherine ULiege et al

in Clinical Chemistry & Laboratory Medicine (2017), 55(3), 378-384

BACKGROUND: We provide a clinical and analytical evaluation of the reformulated version of the Abbott Architect 25-hydroxyvitamin D assay. We compared this assay with three commercial automated ... [more ▼]

BACKGROUND: We provide a clinical and analytical evaluation of the reformulated version of the Abbott Architect 25-hydroxyvitamin D assay. We compared this assay with three commercial automated immunoassays and against a VDSP-traceable liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in six different populations. We also supplemented 40 healthy volunteers with either 600,000 IU of vitamin D2 or 100,000 of vitamin D3 to evaluate the performance of the immunoassays vs. the LC-MS/MS. METHODS: Precision and limit of quantification were assessed, 25(OH)D2 and C3-epimer recovery were calculated. Two hundred and forty samples obtained in healthy Caucasians and Africans, osteoporotic, hemodialyzed and intensive care patients and 3rd trimester pregnant women were analyzed by all methods. Correlation was studied using Passing-Bablok and Bland-Altman analysis. Concordance correlation coefficient (CCC) was calculated to evaluate agreement between immunoassays and LC-MS/MS. We verified if patients were homogeneously classified with the immunoassays when they took vitamin D2 or vitamin D3 after 1, 7 and 28 days. RESULTS: We observed excellent analytical features and showed a very good correlation to the LC-MS/MS results in the overall population. Compared to the other immunoassays, concordance of the new Abbott assay with the LC-MS/MS was at least similar, and often better in diseased populations. Althought the cross-reactivity with 25(OH)D2 was not of 100%, there was no significant difference in the classifications of the patients, either supplemented with D2 or D3 or after 7 or 28 days. CONCLUSIONS: This modified version of the Abbott Architect assay is clearly improved compared to the previous one and presents a better agreement with the LC-MS/MS. [less ▲]

Detailed reference viewed: 46 (1 ULiège)
Full Text
Peer Reviewed
See detailGlomerular filtration rate in healthy living potential kidney donors: a meta-analysis supporting the construction of the the Full Age Spectrum equation.
Pottel, H; Hoste, L; Yayo, E et al

in Nephron (2017), 135(2), 105-119

Detailed reference viewed: 23 (2 ULiège)
Full Text
Peer Reviewed
See detailThe added value of plasma or urinary NGAL concentrations in clinical practice
Gregoire, Emilien ULiege; Claisse, Guillaume; GUIOT, Julien ULiege et al

Poster (2017, January 13)

Detailed reference viewed: 36 (0 ULiège)
Full Text
Peer Reviewed
See detailNewer GFR Estimating Equations Require Validation in Different Populations
DELANAYE, Pierre ULiege; Ebert, N; Pottel, Hans

in American Journal of Kidney Diseases (2017), 70(4), 586

Full Text
Peer Reviewed
See detailConcept de fragilité chez le patient hémodialysé
QUINONEZ, Kevin ULiege; Buckinx, Fanny ULiege; KRZESINSKI, Jean-Marie ULiege et al

in Néphrologie & Thérapeutique (2017), 13(5), 296

Detailed reference viewed: 24 (0 ULiège)